Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes.

Endocrine, metabolic & immune disorders drug targets

Volumn 13, Issue 3, 2013, Pages 256-263

  Tasci, Ilker ^a   Naharci, Mehmet Ilkin ^b   Bozoglu, Ergun ^b   Safer, Umut ^b   Aydogdu, Aydogan ^b   Yilmaz, Basak Filiz ^b   Yilmaz, Gulay ^b   Doruk, Huseyin ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DRUG DERIVATIVE; METFORMIN; NITRILE; PYRROLIDINE DERIVATIVE; VILDAGLIPTIN;

AGED; ARTICLE; BLOOD; COGNITION; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; VERY ELDERLY;

ADAMANTANE; AGED; AGED, 80 AND OVER; COGNITION; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; NITRILES; PROSPECTIVE STUDIES; PYRROLIDINES;

MLCS; MLOWN;

EID: 84899077204     PISSN: None     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/18715303113139990037     Document Type: Article

References (0)